RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
The better safety profile of valdecoxib compared to diclofenac translates into lower medical costs for patients with rheumatoid arthritis
Von Scheele, B., Backhouse, M., Pena, BM., Wong, JM., & Niculescu, L. (2003). The better safety profile of valdecoxib compared to diclofenac translates into lower medical costs for patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 62, 360-360.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.